KMT2A and acute lymphoblastic leukemia: Given that MLL-Af4 drives an AML in mice [32], our current work suggests that IGF2BP3 is a powerful modulator of the leukemic phenotype in the myeloid lineage, in addition to the previously observed effects in human B-ALL cells.